Related Experiment Video
Updated: Jan 6, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
Nutritional management for a lung cancer patient receiving concurrent radiotherapy and immunotherapy and developing
Yanlin Zeng1, Xinmei Zhang2, Di Qin2
1Department of Radiotherapy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China.
Introduction:
Concurrent radiotherapy and immunotherapy is an alternative treatment regimen for elderly patients with locally advanced non-small cell lung cancer (NSCLC) who have contraindications to or decline surgery and chemotherapy. While these patients are susceptible to malnutrition and treatment-related adverse events, experience for their nutritional management is still lacking. In this case report, we summarized the nutritional management process for a NSCLC patient with severe malnutrition, who received concurrent radiotherapy and immunotherapy and developed immune-related dermatitis.
Case Summary:
In March 2024, a 71-year-old male with lung squamous cell carcinoma and severe malnutrition was hospitalized in Cancer Hospital Chinese Academy of Medical Sciences, Shenzhen Center. During concurrent radiotherapy and tislelizumab immunotherapy, the patient developed grade 2 radiation-induced esophagitis and grade 3 immune-related dermatitis. The medical team dynamically assessed the patient's nutritional status, set reasonable nutritional goals, and promptly adjusted nutritional prescriptions according to the severity and cause of the nutritional gap. Key measures included upgrading to combined enteral and parenteral nutrition support during radiation-induced esophagitis complicated by immune-related oral ulcers, adjusting the type of parenteral nutrition formulation for suspected lipid emulsion allergy, and strengthening immunonutrient supplementation during the dermatitis phase. Concurrently, progressive aerobic and resistance exercise training was guided to promote rehabilitation. Via the phased nutritional management, the patient's nutritional indicators significantly improved after 54 days of hospitalization. Anti-tumor treatment was successfully completed, and the dermatitis healed.
Conclusion:
For lung cancer patients complicated with immune-related dermatitis during concurrent radiotherapy and immunotherapy, whole-course management including phased adjustment of nutritional strategies, early differentiation of dermatitis, and integration with exercise rehabilitation may effectively improve nutritional status and promote dermatitis healing, thus supporting the completion of anti-cancer therapy. Further studies with larger sample sizes are required to confirm the effect of nutritional management.
Related Concept Videos
Tumor Immunotherapy
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...